The Impact of Race on Quality of Life of the Aged after Heart Transplant or Destination Therapy Mechanical Support
种族对心脏移植或目的地治疗机械支持后老年人生活质量的影响
基本信息
- 批准号:10282497
- 负责人:
- 金额:$ 6.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAdverse eventAffectAfrican AmericanAgeAge-YearsAgingAlaska NativeAmerican IndiansAsiansCardiac Surgery proceduresCardiologyCardiomyopathiesCitiesClinicalDeath RateDecision MakingDestinationsDevicesDiseaseEthnic OriginHawaiian populationHeart TransplantationHeart failureImplantIncidenceInequalityInteragency Registry for Mechanically Assisted Circulatory SupportKansasKnowledgeLiteratureMechanicsMedicalMinorityModelingNational Institute on AgingOperative Surgical ProceduresOutcomePacific Island AmericansParticipantPatient-Centered CarePatientsPopulationPostoperative PeriodPreparationPrevalenceProceduresPsyche structureQuality of lifeQuestionnairesRaceReportingResearch PersonnelResearch Project GrantsResourcesRiskRisk FactorsSiteSurvival RateSymptomsTimeTrainingTransplant RecipientsTransplantationagedcomparative effectiveness studydata resourceexperiencehealth differencehealth disparityhealth related quality of lifeimprovedinterestleft ventricular assist devicemiddle ageprimary endpointprospectiveracial differencesocial
项目摘要
The purpose of this study is to determine whether older advanced heart failure (HF) patients
who undergo destination therapy mechanical circulatory support (DT MCS), as compared to
patients who undergo heart transplantation (HT), experience non-inferior change in overall
health-related quality of life (HRQOL) and HRQOL domains (physical, mental, and social) by
race from baseline to 1 year post-operatively. Advanced HF patients, 60-80 years of age, are an
appropriate target group for this proposed study because they are receiving HTs and implant of
MCS devices more frequently, and despite a greater risk for poor clinical outcomes, they have
acceptable rates of survival. While studies have examined overall survival, few have considered
HRQOL of older minority patients who undergo HT or DT MCS. MY proposed study may
contribute to better patient-centered care of older minority advanced HF patients, by informing
decision making and guiding strategies to enhance post-operative HRQOL. I will leverage the
data resources of Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical
Support? (SUSTAIN-IT) (National Institute on Aging # R01AG047416, 7/15/15 – 3/31/21).
SUSTAIN-IT is a multi-site, observational, prospective, longitudinal, comparative effectiveness
study. I will use a theoretical framework which models the influence of disease, treatment,
adverse events, and symptoms on HRQOL to guide this proposed study. The primary aim is to
determine whether older advanced HF patients who undergo DT MCS, as compared to patients
who undergo HT (with or without MCS) experience non-inferior change in overall HRQOL
(primary endpoint, using the heart failure-specific Kansas City Cardiomyopathy-12 questionnaire
summary score), and HRQOL domains by race (white versus all minorities) from baseline to 1
year post-operatively. The secondary Aim is to determine whether race is a risk factor related to
overall HRQOL (using the Kansas City Cardiomyopathy-12 heart-failure specific questionnaire
summary score as the dependent variable), for patients who undergo DT MCS and HT at 1 year
post-operatively.
这项研究的目的是确定年龄较大的晚期心力衰竭(HF)患者是否
谁接受了目的地治疗机械电路支持(DT MCS)
接受心脏移植(HT)的患者,整体上经历了非上限变化
与健康相关的生活质量(HRQOL)和HRQOL领域(身体,精神和社交)
术后1年的基线比赛。高级HF患者,60-80岁,是
这项拟议研究的适当目标组,因为他们正在接受HTS和植入
MCS设备更频繁,并且会出现更大的临床结果风险,它们具有
可接受的生存率。尽管研究检查了总体生存,但很少有人考虑
患有HT或DT MC的老年少数族裔患者的HRQOL。我建议的研究可能
通过通知
决策和指导策略以增强术后HRQOL。我将利用
维持老年人生活质量的数据资源:心脏移植或机械
支持? (Sustain-IT)(国家老化研究所#R01AG047416,7/15/15 - 3/31/21)。
sustain-it是多站点,观察性,前瞻性,纵向,比较效率
学习。我将使用一个理论框架,该框架模拟了疾病,治疗的影响,
不良事件和HRQOL的症状指导这项拟议的研究。主要目的是
与患者相比,确定年长的高级HF患者是否接受DT MCS
谁经历了HT(有或没有MCS)经历了整体HRQOL的非上限变化
(主要终点,使用特定于心力衰竭的堪萨斯城心肌病-12问卷
摘要得分),以及从基线到1的种族(白与所有少数民族)按种族(白人与所有少数民族)
术后年。次要目的是确定种族是否是与
总体HRQOL(使用堪萨斯城的心脏病 - 12
摘要得分作为因变量),对于接受DT MC和HT的患者1年
术后。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jerian Dixon-Evans其他文献
Jerian Dixon-Evans的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children
用于儿童抗病毒治疗的剂量灵活组合 3D 打印输送系统
- 批准号:
10682185 - 财政年份:2023
- 资助金额:
$ 6.94万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 6.94万 - 项目类别:
Early life stress impacts molecular and network properties that bias the recruitment of pro-stress BLA circuits
早期生活压力会影响分子和网络特性,从而影响促压力 BLA 回路的募集
- 批准号:
10820820 - 财政年份:2023
- 资助金额:
$ 6.94万 - 项目类别:
Developing a Risk Index for Functional Decline in Middle-Aged and Older Adults with HIV
制定中老年艾滋病毒感染者功能衰退的风险指数
- 批准号:
10762280 - 财政年份:2023
- 资助金额:
$ 6.94万 - 项目类别:
Development and implementation of a digital sleep intervention for preschoolers in foster care
为寄养中的学龄前儿童开发和实施数字睡眠干预
- 批准号:
10724304 - 财政年份:2023
- 资助金额:
$ 6.94万 - 项目类别: